Sondex PLC
01 June 2007
1 June 2007
Sondex PLC
Application for Admission of Ordinary Shares and update on Total Voting Rights
Applications have been made to the UKLA and London Stock Exchange for 135,364
Ordinary Shares of 10 pence each to be admitted to the Official List and to
trading on the London Stock Exchange's market. The shares for which application
is now being made are being issued as deferred consideration for the
acquisition of Applied Electronic Systems Inc. on 13 December 2005. Dealing is
expected to commence on 6 June 2007.
Following this issue the total voting rights in Sondex plc will be 56,948,846.
This figure may be used by shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in, Sondex PLC under the FSA's Disclosure and
Transparency Rules.
1 June 2007
Enquiries:
Sondex Tel: 0125 286 2200
Martin Perry (Chief Executive)
Chris Wilks (Finance Director)
College Hill Tel: 020 74572020
Nick Elwes
Paddy Blewer
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.